CID-25014542
CAS No. 220904-99-4
CID-25014542( CID-25014542 | CID25014542 | CID 25014542 )
Catalog No. M17441 CAS No. 220904-99-4
CID-25014542 is novel inhibitor of Raf kinases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 39 | In Stock |
|
| 5MG | 37 | In Stock |
|
| 10MG | 59 | In Stock |
|
| 25MG | 111 | In Stock |
|
| 50MG | 165 | In Stock |
|
| 100MG | 240 | In Stock |
|
| 200MG | 337 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCID-25014542
-
NoteResearch use only, not for human use.
-
Brief DescriptionCID-25014542 is novel inhibitor of Raf kinases.
-
DescriptionCID-25014542 is novel inhibitor of Raf kinases.
-
In Vitro——
-
In Vivo——
-
SynonymsCID-25014542 | CID25014542 | CID 25014542
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
RecptorRaf
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number220904-99-4
-
Formula Weight429.49
-
Molecular FormulaC15H8Br2ClNO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (232.83 mM)
-
SMILESc1cc2c(cc1Cl)/C(=C/c1cc(c(c(c1)Br)O)Br)/C(=O)N2
-
Chemical Name(3Z)-5-Chloro-3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-1H-indol-2-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lulli D, Carbone ML, Pastore S. The MEK Inhibitors Trametinib and Cobimetinib Induce a Type I Interferon Response in Human Keratinocytes. Int J Mol Sci. 2017 Oct 24;18(10)
molnova catalog
related products
-
N-Desmethylclozapine
N-Desmethylclozapine is an antagonist of serotonin (5-HT) receptor subtype 5-HT2C (IC50: 7.1 nM). It also is an antagonist at dopamine D4 receptors an agonist at δ-opioid receptors.
-
2-Methyl-5-HT
2-Methyl-5-HT is a potent and selective 5-HT3 receptor agonist with anti-depressive-like effects.
-
Cerlapirdine
Cerlapirdine is a selective, potent, full antagonist of the 5-hydroxytryptamine 6 (5-HT6) receptor. Cerlapirdine is already in clinical development for the treatment of cognitive disorders related to Alzheimer's disease and schizophrenia. It works by acting as a selective 5-HT6 receptor antagonist.
Cart
sales@molnova.com